Competence synergies are a key aspect of orphanix’ mission. We complement portfolios in the paediatric rare disease space of fully integrated pharmaceutical companies with a strong field force. Partnering enables us to expand our scope in developing new treatments.
orphanix offers novel ready-to-implement products as well as commercialization through licensing and/or co-development.
If you are interested in exploring partnership opportunities with orphanix, please contact BD Executive Mårten Österlund at marten@orphanix.com.